Want to let Trump know how you feel about marijuana’s Schedule 1 classification? Now’s your chance. And here’s how.
From now until April 23, the Food and Drug Administration is taking public comment on the topic, specifically concerning the “abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on availability for medical use of” cannabis and its compounds. According to the Federal Register, the comments will be considered in preparing a response from the U.S. to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs.
-
Related Story:Â 5 Deadly Drugs The Government Says Are Safer Than Marijuana
WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. It’s the first-ever review of marijuana’s current classification.
Click here to leave your two-cents online. It’s a quick process that also allows commenters the option of attaching supporting documentation. (Including your contact information is also optional.) You can also mail in your comments.
As a Schedule 1 drug, as it’s currently classified, marijuana is denied prescription medical use and is considered a high potential for abuse. It also means lack of rigorous scientific testing on the drug, because of the federal government’s restrictions on obtaining it,
-
Related Story:Â The War On Drugs Is Holding Science Back From Helping Patients
If the WHO ends up supporting the rescheduling of cannabis, it will only help to change marijuana’s status in countries across the globe.
